A young Peninsula drugmaker won regulatory approval Friday for a rare-disease drug picked up in a deal two years ago.
After asset purchase from Travere, Mirum's Ctexli crosses FDA finish line in rare metabolic disorder
The approval makes chenodiol—already cleared for decades to treat radiolucent gallstones under the brand name Chenodal—the ...
Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...
Commissions do not affect our editors' opinions or evaluations. Names are a significant piece of our identity. When a child’s name no longer suits them due to a familial change, personal ...
But Audi executives confirmed last year the brand was moving away from this strategy, with subsequent models like the A6 e-tron using variant names like ‘Performance’ to indicate where a vehicle sits ...
Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're about to lose access.
Nintendo is arguably taking the safe route with the name of its Switch "successor ... Layden noted how it simply comes down to "brand value": Shawn Layden: "They've [Nintendo] created so ...
An internal investigation by the broadcaster examined eight complaints involving Brand when he was a radio presenter. By Reggie Ugwu An investigation by the BBC of allegations against the comedian ...
Denza – the luxury sub-brand of BYD – has been confirmed for Australia with one of the first models likely to include a Prado-rivalling off-road hybrid SUV.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback